<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">OSs, however, do not provide the final answer. Based on OSs, one cannot be certain that the recommendations are accurate and to assess if one drug is better or safer than another. Importantly, harm related to therapy cannot be excluded even after application of multiple adjustment techniques [
 <xref ref-type="bibr" rid="CR22">22</xref>]. The conclusions of these studies, therefore, should not be taken as a surrogate for appropriate randomized data to guide the management with RAASi in the COVID-19 context [
 <xref ref-type="bibr" rid="CR22">22</xref>].
</p>
